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5-azacytidine affects TET2 and 
histone transcription and reshapes 
morphology of human skin 
fibroblasts
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Fulvio Gandolfi1 & Tiziana A.L. Brevini1
Phenotype definition is controlled by epigenetic regulations that allow cells to acquire their 
differentiated state. The process is reversible and attractive for therapeutic intervention and for the 
reactivation of hypermethylated pluripotency genes that facilitate transition to a higher plasticity state. 
We report the results obtained in human fibroblasts exposed to the epigenetic modifier 5-azacytidine 
(5-aza-CR), which increases adult cell plasticity and facilitates phenotype change. Although many 
aspects controlling its demethylating action have been widely investigated, the mechanisms underlying 
5-aza-CR effects on cell plasticity are still poorly understood. Our experiments confirm decreased global 
methylation, but also demonstrate an increase of both Formylcytosine (5fC) and 5-Carboxylcytosine 
(5caC), indicating 5-aza-CR ability to activate a direct and active demethylating effect, possibly 
mediated via TET2 protein increased transcription. This was accompanied by transient upregulation of 
pluripotency markers and incremented histone expression, paralleled by changes in histone acetylating 
enzymes. Furthermore, adult fibroblasts reshaped into undifferentiated progenitor-like phenotype, 
with a sparse and open chromatin structure. Our findings indicate that 5-aza-CR induced somatic 
cell transition to a higher plasticity state is activated by multiple regulations that accompany the 
demethylating effect exerted by the modifier.
DNA methylation is essential for mammalian development, gene regulation, genomic imprinting, and chro-
matin structure1. Changes in methylation allow mature cells of adult organisms to acquire their differentiated 
state through a gradual loss of potency2 and a progressive restriction in their options3.
The process is reversible and may be altered by biochemical and biological manipulation, making it an attrac-
tive target to reactivate hypermethylated pluripotency genes4 and facilitate cell transition to a higher plasticity 
state5.
The epigenetic modifier 5-azacytidine (5-aza-CR) is a chemical analogue of cytosine. It is known to induce 
reversible cell cycle arrest6,7 and acts as a direct inhibitor of methyltransferase activity, decreasing methylation in 
newly synthesised DNA. The molecule substitutes for cytosine, incorporates into DNA and RNA, during replica-
tion8,9, forms covalent adducts with DNA methyltransferase (DNMT) 1, thereby depleting the cells from enzyme 
activity, causing demethylation of genomic DNA8,10, as well as gene reactivation11. Thanks to its powerful effects, 
this compound may be used to increase chromatin plasticity and facilitate phenotype changes12,13. Several studies 
reported 5-aza-CR ability to facilitate adult somatic cell switch from one phenotype to a different one14–16. In 
particular, we demonstrated that a short exposure to 5-aza-CR allows a transient passage through a plastic chro-
matin state. This is sufficient to allow a complete directed differentiation of an adult mature cell into a different 
cell type17–20.
All these studies are very promising because they allow to obtain safe and viral vector free cells that may 
be used for regenerative medicine. However, the mechanisms underlying 5-aza-CR effects on cell plasticity 
and differentiation are still poorly understood and need to be better elucidated. In this manuscript we expose 
5-aza-CR treated cells either to: 1) embryonic stem cell (ESC) medium (to promote and maintain cell plasticity); 
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2) pancreatic differentiation (PANCR) medium (to encourage and boost differentiation); 3) standard fibroblast 
(FB) culture medium (to allow cells to revert to their original phenotype).
We analyze the global methylation changes taking place in cells exposed to the epigenetic modifier and in the 
different experimental conditions tested. Based on preliminary Whole Transcriptome Analysis, obtained with 
an Applied Biosystems SOLiD 5500xl Sequencer, we investigate in details changes in transcriptions of the TET 
family genes, that affect methylation21,22 and play an essential role in pluripotency regulation of ESC21,22 and in 
the very early stage of somatic cell reprogramming toward induced Pluripotent Stem Cells (iPSCs)23. We study 
whether upregulation of TET2 results in increased levels of 5-Formylcytosine (5fC) and 5-Carboxylcytosine 
(5caC), which are both products of TET2 enzyme-mediated oxidation of 5-methylcytosine. This would suggest 
the possibility of a direct demethylating mechanism, accompanying the well documented indirect DNMT related 
action. To further support this hypothesis, we then investigate the effect of siRNA TET2 on the global DNA 
demethylation caused by 5-aza-CR. We also analyze the expression of histones belonging to the 1, 2 A, 2B, 3 and 
4 families. Furthermore, we characterize the ultrastructural phenotypic modifications related to the exposure to 
5-aza-CR and to the different culture conditions.
The data presented confirm the well-known effect on methylation but also highlight new cellular targets 
accompanying 5-aza-CR effects on epigenetic regulation of cell plasticity and differentiation.
Results
Global methylation changes in response to 5-aza-CR. Exposure to 5-aza-CR induced a significant 
decrease of global DNA methylation (Fig. 1a). In particular, human fibroblasts (T0) treated for 18 hours with the 
epigenetic modifier (Post 5-aza-CR), showed a significant decrease in DNA methylation. Cells maintained com-
parable methylation levels when they were cultured in ESC medium for 24 and 48 hours respectively (24 h ESC; 
48 h ESC). In contrast, methylation significantly increased in cells exposed to PANCR medium (24 h PANCR; 48 h 
PANCR) as well as in those returned to FB medium (24 h FB; 48 h FB). No methylation changes were observed 
in cells that were cultured in the different media, without a previous exposure to 5-aza-CR (MEDIUM ESC; 
MEDIUM PANCR; MEDIUM FB), indicating that the medium alone is not able to affect DNA methylation levels 
in differentiated cells.
Human fibroblasts acquire a transient high plasticity state after epigenetic erasing with 
5-aza-CR. Methylation decrease was accompanied by the up-regulation of the ten-eleven translocation 2 
(TET2) gene (Fig. 1c, Post 5-aza-CR). However, the modifier did not affect all the TET family members, but 
rather it exerted a distinct effect on TET2 transcription, while no significant effect was observed for TET1 and 
TET3.
5-aza-CR also induced the onset of pluripotency gene expression [POU class 5 homeobox 1 (OCT4), sex 
determining region Y-box 2 (SOX2), Nanog homeobox (NANOG), and ZFP42 zinc finger protein (REX1)] 
(Fig. 1b, Post 5-aza-CR). ESC medium maintained high expression levels of all these genes for the first 2 days of 
culture. By contrast, pluripotency gene expression significantly decreased by day 2, when post 5-aza-CR cells were 
cultured in differentiation media (Fig. 1b; 2d, 4d, 6d PANCR; 2d, 4d, 6d FB). Furthermore, even when maintained 
in ESC medium over a longer period of time, cells turned down the transcription of these genes by day 6 of culture 
(Fig. 1b; 6d ESC).
TET2 upregulation resulted in 5-Formylcytosine and 5-Carboxylcytosine increase. 5-aza-CR 
induced TET2 upregulation resulted in significant increase of 5fC and 5caC (Fig. 1d and Suppl. Figure 1). These 
increased levels were also present in cells cultured in ESC medium for 24 h and 48 h (24 h ESC; 48 h ESC), while 
decreased when cells were transferred to PANCR (24 h PANCR; 48 h PANCR) and FB (24 h FB; 48 h FB) media. 
No changes were observed in cells that were cultured in the different media, without a previous exposure to 
5-aza-CR (MEDIUM ESC; MEDIUM PANCR; MEDIUM FB).
TET2 downregulation affects 5-aza-CR induced global DNA demethylation. Global DNA 
demethylation induced by 5-aza-CR was decreased in response to TET2 RNA silencing (Fig. 1a). Significant 
differences in methylation levels were also detected in cells cultured in ESC medium (24 h ESC; 48 h ESC). No 
differences were detected in the other groups (T0; 24 h PANCR; 48 h PANCR; 24 h FB; 48 h FB; MEDIUM ESC; 
MEDIUM PANCR; MEDIUM FB).
5-aza-CR modulates expression of histones and histone acetylating enzymes in human fibro-
blasts. Expression analysis demonstrated 5-aza-CR ability to significantly upregulate the transcription of his-
tones within the 1, 2, 3 and 4 families, and their encoded protein (Figs 2 and 3). Histones showed a significant 
increase post 5-aza-CR and persisted at high levels in cells cultured in ESC medium for 24 h and 48 h (24 h ESC; 
48 h ESC). In contrast, their expression levels were significantly down-regulated when cells were transferred to 
PANCR (24 h PANCR; 48 h PANCR) and returned to values comparable to T0 after 48 h in FB medium (48 h FB). 
No significant change was detected in cells cultured in the different media, without prior exposure to 5-aza-CR.
5-aza-CR did not affect the expression of HIST1H2AC (H2A type 1-c) and HIST2H2AC (H2A type 2-C, 
Figs 3 and 4). Moreover, we detected a parallel downregulation of a fibroblast specific gene (COL6A3) as well as a 
decreased expression of a transcript involved in cell cycle control (CCNG1). Furthermore, increased expression 
of histones was supported by the upregulation of the acetylating enzyme Histone acetyltransferase 1 (HAT1) and 
by the decreased expression of the Histone deacetylase enzyme 1 (HDAC1).
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Figure 1. (a) Global DNA methylation of cells before and after siRNA transfection, exposed to 5-aza-CR 
and to different treatments for 24 and 48 hours. Highest expression set to 1 and all other times relative to this. 
Bars represent the mean ± SD of two independent experiments with three independent replicates, obtained 
from three different fibroblast primary lines. Different superscripts denote significant differences between 
groups (P < 0.05). (b) 5-aza-CR treatment induced the onset of pluripotency gene expression, increasing the 
transcription of OCT4, SOX2, NANOG and REX1 (Post 5-aza-CR). Culture in ESC medium for two days 
(2d ESC) maintained upregulated expression of all the genes, that are turned down by day 6 of culture (6d 
ESC). 5-aza-CR treated cells (Post 5-aza-CR) display pluripotency gene transcription levels in the range of 
45% of those detected in human ESC (hESC) and iPSC (hiPSC). Gene expression levels are reported with the 
T0 expression set to 1 and all other times relative to this. Different superscripts denote significant differences 
between groups (P < 0.05). (c) Effect of 5-aza-CR on TET gene family transcription. The modifier upregulated 
TET2, while leaving the other TET members unchanged. Gene expression levels are reported with the T0 
expression set to 1 and all other times relative to this. Different superscripts denote significant differences 
between groups (P < 0.05). (d) DNA dot blot analysis of 5-Formylcytosine (5fC) and 5-Carboxylcytosine (5caC) 
in cells exposed to 5-aza-CR and to different treatments for 24 and 48 hours.
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5-aza-CR affects cell morphology and chromatin organization. T0 cells displayed a typical fibro-
blast morphology and were characterized by nuclei with condensed areas close to the nuclear membrane and 
Figure 2. Histone transcription changes in adult human skin fibroblasts exposed to 5-aza-CR and 
subjected to three different culture conditions for 24 and 48 hours. Transcription was affected by the 
epigenetic eraser and persisted at high levels in cells cultured in ESC medium (24 h and 48 h ESC). It decreased 
when post 5-aza-CR cells where exposed to differentiation media. (24 h and 48 h PANCR; 24 h and 48 h FB). 
Gene expression levels are reported with the highest expression set to 1 and all other times relative to this. 
Different superscripts denote significant differences between groups (P < 0.05).
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large vacuoli. The perinuclear compartment contained rough endoplasmic reticulum cisternae (RER), widely 
scattered mitochondria, vesicles and electron dense granules (Fig. 5 panels a–c).
Figure 3. Histone protein levels in adult human skin fibroblasts exposed to 5-aza-CR and subjected to 
three different culture conditions for 24 and 48 hours. 5-aza-CR significantly increased histone protein 
concentrations that persisted at high levels in ESC medium (24 h and 48 h ESC). Protein levels decreased when 
post 5-aza-CR cells were cultured in differentiation media. (24 h and 48 h PANCR; 24 h and 48 h FB). Notably no 
changes were detected for H2A type 1-C and H2A type 2-C. Different superscripts denote significant differences 
between groups (P < 0.05).
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Count in semi-thin sections demonstrated that 86,31 ± 4,13% cells remarkably changed their morphology 
after exposure to 5-aza-CR, showing a reduced cell size and either few short microvilli on the plasma membrane 
or a smoth cell surface. At higher magnification, in the electron-lucent cytoplasm, we could detect large roundish 
or lobed nuclei that displayed a global chromatin decondensation, mitochondria, RER, empty or filled vacu-
oles (Fig. 5 panel d), as well as numerous lysosomes and autophagosomes (Fig. 5 panel e). Simultaneously with 
the autophagic phenomena, a cytoplasmic peripheral ring, less dense and organule-free, became visible (Fig. 5 
panel f), which is likely to be responsible for a final reduction in cell size. These morphological features, that are 
typically related to a high plasticity phenotype24, were maintained by 84,24 ± 5,05% and 83,74 ± 5,52% of cells 
cultured in ESC medium for 24 h and 48 h respectively, as confirmed at higher magnification (Fig. 5 panels g–i), 
possibly suggesting that, once acquired, the increased plasticity state can be sustained by signals derived from 
medium.
Interestingly, cells returned to FB medium after exposure to 5-aza-CR re-established the fibroblast phenotype 
(Fig. 5 panels j–l), indicating that the effect of the modifier is reversible and allows the re-acquisition of the orig-
inal cell phenotype.
When post 5-aza-CR cells were transferred to PANCR medium, which has been previously shown to address 
them towards the pancreatic endoderm differentiation17, they adopted a completely different spatial organiza-
tion. After 24 hours in this medium, 80,12 ± 4,41% cells were variously shaped and showed numerous and long 
cytoplasmic projections. At higher magnification, nuclei were characterized by indented profiles, clustered dense 
chromatin close to the nuclear envelope and prominent nucleoli (Fig. 6 panels a, b, d, e). Cytoplasm contained 
mitochondria, lysosomes, granules and numerous vacuoles which enclosed materials of different electron density 
(Fig. 6 panels c, d, f). Numerous RER dilated cisternae, wrapping fine reticular network could be appreciated close 
to the cell surface (Fig. 6 panels a, c). At 48 hours, the same rate of cells had spotted contacts (Fig. 6 panels g, i) 
or became tightly attached due to the presence of gap-like junctions (Fig. 6 panel h). Cytoplasmic bridges among 
adjacent cells were visible (Fig. 6 panel j). Vacuoles with heterogeneous material, granules and autophagosomes 
were present in the inner region of cytoplasm, while bundles of filaments were localized at the periphery of the 
cells (Fig. 6 panel k).
Discussion
The epigenetic modifier 5-aza-CR has been shown to incorporate into DNA during cell replication, leading to a 
global demethylation and gene reactivation11. Thanks to this powerful effects, the compound has been used to 
increase chromatin plasticity and facilitate phenotype changes in different models12,13,17–20. Although the DNA 
demethylation capabilities of 5-aza-CR have been well characterized, both in vitro and in vivo, there is also rea-
son to believe that this drug exhibits alternative mechanisms of action25,26. Here we confirm the global effect on 
methylation and, as shown in Fig. 1a, we detect a decreased methylation in fibroblasts exposed to 5-aza-CR. These 
levels are maintained in cells cultured in ESC medium, suggesting that DNA methylation levels may be modu-
lated by the milieu of the cells, including signals deriving from the medium. These findings are in agreement with 
Blaschke et al.27 and Yin et al.28 that demonstrated changes in DNA methylation in response to specific media 
formulation and the contained nutritional factors. This possibility is also confirmed by the observation that cells, 
treated with the modifier, but exposed to FB medium and or PANCR medium, restored their methylation levels. 
Interestingly, the changes described were accompanied by an increased expression of several genes. Following 
preliminary NGS analysis of untreated fibroblasts vs. 5-aza-CR exposed cells, we here confirm upregulated 
transcription of the TET2 gene, which has been recently shown to support 5-aza-CR dependent demethylation 
Figure 4. A gene specific effect accompanies 5-aza-CR demethylating action. Exposure to the modifier 
didn’t affect the transcription of several histones (HIST1H2AC, HIST2H2AC and HIST1H4E), or resulted 
in downregulation of COL6A3 and CCNG1. Furthermore, a sharp upregulation of HAT1, and a decrease of 
HDAC1 was detected after exposure to 5-aza-CR. Different superscripts denote significant differences between 
groups (P < 0.05).
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process in hepatocarcinoma cell lines29. In particular, we show that upregulation of TET2 results in an increase 
of both 5fC and 5caC (Fig. 1d), indicating 5-aza-CR ability to activate a direct and active demethylating effect, 
possibly mediated via TET2 protein. Furthermore, the possibility of a synergistic action between direct and indi-
rect demethylation processes is also demonstrated thank to TET2 siRNA experiments, where we demonstrate 
that downregulation of TET2 protein results in an overall decrease of global DNA demethylation (Fig. 1a), that 
however still persist in response to 5-aza-CR, possibly due to the unaffected action of 5-aza-CR on DNMTs.
TET2 upregulation is also in agreement with the acquisition of the higher plasticity state detected in post 
5-aza-CR cells, since TET2 has been reported to have a role in pluripotency induction and maintenance30. 
Figure 5. 5-aza-CR induced cell plasticity is unravelled by morphological changes. The distinct 
fibroblastoid morphology (panels a–c) change after exposure to 5-aza-CR (panels d–f) with the acquisition of 
an undifferentiated progenitor-like phenotype characterized by nuclei (n) showing chromatin decondensation 
(panels d, f) and autophagic phenomena (panel e, arrowhead). Cells can be characterized by cytoplasmic 
peripheral ring without organules that are present in the perinuclear area (panel f, white arrow). Post 
5-aza-CR cells cultured in ESC medium (panels g–i) maintain the undifferentiated phenotype (n: nucleus; 
autophagosomes: arrowhead). Post 5-aza-CR cells cultured in FB medium (panels j–l) show re-established 
features typical of fibroblasts. Scale bars: a, 2.5 μ m; b,1 μ m; c,1 μ m; d, 2 μ m; e,0.8 μ m; f, 2 μ m; g, 4 μ m; h, 1.4 μ m; i, 
0.6 μ m; j, 2 μ m; k, 2 μ m; l, 1.7 μ m.
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Interestingly, 5-aza-CR did not affect all the members of the TET family, but rather it exerted a distinct effect on 
TET2, leaving the other members unchanged. Based on previous observations, showing that TET2 does not affect 
methylation levels at gene promoters and transcription start sites, but, in contrast, mainly regulates gene bodies 
and exon boundaries, our results suggest the possibility of a specific effect of the modifier on the latter.
Exposure to 5-aza-CR also caused the onset of pluripotency gene expression, such as OCT4, NANOG, REX1 
and SOX2 (Fig. 1b). As shown in Fig. 1b, these genes were induced by 5-aza-CR, displaying transcription levels 
in the range of 45% of those detected in human ESCs and iPSCs. This result is also consistent with the molecule 
ability to reactivate previously silent genes and to alter the differentiation state of eukaryotic cells, as well as with 
Figure 6. Post 5-aza-CR cells cultured in PANCR medium (panels a–k) show peculiar morphological 
changes. After 24 hours, cells are characterized by cytoplasmic projections (panel a), indented nuclei (n) 
(panels a, b, d, e) and large nucleoli. The cytoplasm is occupied by numerous organules, large dilated cisternae 
of endoplasmic reticulum (panels a, c, arrowheads) and autophagosomes (panel f, arrowhead). After 48 hours, 
cells can be in close contact (panels g, detail; i, white arrowehead) or tightly joined by gap-like junction (see 
enlargement in panel h) or can show cytoplasmic bridges (panel j, arrows). In the cytoplasm, phagolysosomes 
(panel j, arrowhead) and bundles of filaments (panel k, arrowhead) are visible. Scale bars: a, 2 μ m; b, 2 μ m;  
c, 3.3 μ m; d, 1.7 μ m; e, 1.4 μ m; f, 0.5 μ m; g, 2 μ m; i, 1 μ m; j, 1.3 μ m; k, 0.5 μ m.
www.nature.com/scientificreports/
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recent data showing that 5-aza-CR demethylation of one or more loci facilitates a rapid and stable transition of 
partially reprogrammed iPSCs to a fully reprogrammed state31.
Interestingly, culture in ESC medium maintained upregulated expression of all the genes described, suggesting 
the acquisition of a high plasticity state. However, this condition was transient and reversible, since expression of 
pluripotency related genes decreased gradually when post 5-aza-CR cells where exposed to differentiation media 
(24 h and 48 h PANCR; 24 h and 48 h FB). Furthermore, even when maintained in ESC medium over a longer 
period of time, cells turned down the transcription of these genes by day 6 of culture (Fig. 1b).
The expression of histones belonging to 1, 2, 3 and 4 families was also affected by the exposure to the epi-
genetic eraser. The genes and their encoded proteins showed increases (between 3 to 11 fold), in cells treated 
with 5-aza-CR, and persisted at high levels in cells cultured in ESC medium for 24 and 48 hours (Figs 2 and 3). 
The effect on transcription was evident in replication-dependent as well as in replication-independent histones, 
indicating that it may not only be a secondary indirect consequence of 5-aza-CR on the cell cycle. Furthermore, 
histones belonging to the same cluster was either upregulated or unchanged by 5-aza-CR, suggesting a histone 
specific effect rather than a cluster specific one. We have no ready explanation for this, although it is known that 
separate sets of histone genes are transcribed in a precise temporal sequence during development and differenti-
ation of lower species32. On the other hand, the contribution of histone transcription to the maintenance of high 
plasticity versus differentiation in mammalian is presently still to be fully understood and further studies are 
required.
We postulate that the 5-aza-CR effect on histone gene transcription is unlikely to be accounted for a general 
demethylating effect, since exposure to the modifier, resulted in parallel downregulation of fibroblast specific 
genes (COL6A3) as well as of transcripts involved in the control of cell cycle (CCNG1) and did not affect the 
expression of several histones genes (HIST1H2AC, HIST2H2AC and HIST1H4E, Fig. 4). In agreement with 
this hypothesis, Komashko et al. demonstrated that several changes in gene expression after 5-aza-CR treat-
ment were related to an alternative DNA-hypomethylating independent effect33. Furthermore, consistent with 
the idea that this epigenetic modifier has additional modes of action, several works indicated that 5-aza-CR 
can induce expression of genes lacking CpG methylation34,35. Interestingly, Takebayashi et al. demonstrated a 
DNA methylation independent mechanism, directly related to an increase in histone hyperacetylation25. This 
is also in agreement with our observation that HAT1 transcription was significantly higher in cells exposed 
to 5-aza-CR, suggesting the possible correlation among the exposure to the modifier, the overexpression of 
HAT1, the consequent histone hyperacetylation and increased transcription. This possibility is further sup-
ported by the parallel decreased expression of HDAC1 (Fig. 4), reported in our manuscript. It is also coher-
ent with previous works that show how modulation of histone acetylation is an integral component of gene 
expression control36 and demonstrate a key role of the specific enzymatic activity of HDACs in transcriptional 
regulation37.
Morphological analysis further unravelled the impact of 5-aza-CR on cell plasticity and differentiation. In 
particular, it is interesting to underline that adult skin fibroblasts changed after 5-aza-CR exposure, became 
smaller in size and reshaped into an undifferentiated progenitor-like phenotype. In this condition, cells showed 
a nuclei/cytoplasm ratio similar to what previously described in hESCs38 and in hiPSCs obtained from human 
dermal fibroblasts39. 5-aza-CR increased plasticity was also accompanied by autophagic phenomena, that have 
been reported to play a critical role in the maintenance of adult stem cells40, possibly reducing senescence via 
the active removal of oxigen reactive species41. Interestingly the presence of autophagic vacuoles have been 
previously reported in ultrastructural analysis of hiPSC42. Furthermore, post 5-aza-CR cell nuclei were charac-
terized by sparse chromatin and appeared devoid of compact formations. This is consistent with the observa-
tion that an open chromatin structure is required for a high plasticity state43 and is a common feature of iPSC 
and, more in general, one of the hallmark of stem cells43,44. Interestingly, this condition was maintained by ESC 
medium, possibly suggesting that, once acquired, the decreased methylation state can be sustained by factors 
contained in the medium such as LIF, which has been recently demonstrated to induce murine cell hypometh-
ylation45. The acquisition of a transient high plasticity state is also consistent with post 5-aza-CR cell ability 
to respond to differentiation protocols and acquire a differentiated phenotype17–20. Indeed, when 5-aza-CR 
treated cells were transferred to PANCR medium, which address them towards the pancreatic endoderm dif-
ferentiation17, they adopted a different phenotype. Nuclei were characterized by indented profiles, prominent 
nucleoli and clustered dense chromatin, mostly locating close to the nuclear envelope. These morphological 
changes, involving a packed chromatin conformation, and its clustering near the nuclear envelope, have been 
previously described and considered to be distinctive of a differentiated state24 and suggest that post 5-aza-CR 
cells may reverse their high plasticity state and respond to differentiation stimuli. This is consistent with the 
methylation and transcriptional changes described above and indicates that the mechanisms exerted by the 
modifier have also deep effects at the phenotype level. Such hypothesis is further supported by the observation 
that the majority of cells showed gap-like junctions and cytoplasmic bridges, all features required to guarantee 
a correct differentiation processes46,47.
The reversibility of the effects exerted by 5-aza-CR, was confirmed by the re-acquisition of the original pheno-
type when cells were returned to FB medium, indicating that a short exposure to the modifier allows a transient 
high plasticity chromatin state, sufficient to allow cell reshaping.
Altogether, the data presented in this manuscript, indicate 5-aza-CR ability to increase TET2 gene expres-
sion, modulate transcription of histones and histone acetylating enzymes, which result in specific mor-
phological changes. Moreover, the results obtained, also suggest the molecule ability to interfere with DNA 
methylation through a direct TET2-mediated mechanism, that accompanies the well-known indirect DNMT 
related one.
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Experimental Procedures
All chemicals were purchased from Life Technologies (Italy) unless otherwise indicated.
Ethics statement. Adult human skin fibroblast primary lines were kindly donated by Dr. Gianpaolo Zerbini 
(Scientific Institute San Raffaele). Cells were isolated from adult patients aged between 35 and 49 years, after 
written informed consent and approved by the Ethical Committee of the Department of Internal Medicine of the 
University of Genoa. All the methods in our study were carried out in accordance with the approved guidelines.
Skin fibroblast culture (FB). Three adult skin fibroblast primary lines were isolated from human healthy 
patients and grown in standard culture medium (FB), consisting of DMEM with 20% (vol/vol) Fetal Bovine 
Serum (FBS), 2 mM glutamine (Sigma), and antibiotics (Sigma). Cells were passaged twice a week in a 1:3 ratio. 
All experiments were performed in triplicate.
5-aza-CR treatment. Fibroblasts were plated in 4-well multidish (Nunc) previously treated with 0.1% gel-
atin (Sigma) at concentration of 7.8 × 104 cell/cm2. They were then incubated with 1 μ M 5-aza-CR (Sigma) for 
18 hours. Concentration and time of exposure were selected according to our previous work17.
Experimental design. At the end of 5-aza-CR treatment cells were divided in three experimental groups 
and cultured for 24 and 48 hours, 4 and 6 days. In the first group, cells were returned in FB medium. The second 
group of cells were cultured in medium specific for pluripotency maintenance (ESC). Cells of the last group we 
differentiated toward pancreatic lineage (PANCR).
Medium for pluripotency maintenance (ESC). Cells were cultured in DMEM low glucose/ Ham’s F-10 
Nutrient Mix (1:1) supplemented with 10% KnockOut Serum Replacement, 5% FBS, 1% antibiotics (Sigma), 
0.1 mM β - mercaptoetanol (Sigma), 2 mM glutamine (Sigma), 1 mM MEM Non-Essential Amino Acids, 1% 
Nucleoside mix, 20 ng/ml Recombinant Human FGF basic (bFGF) and 103 units/ml ESGRO (LIF)48.
Medium for pancreatic induction (PANCR). Cells were cultured in Dulbecco’s Modified Eagle Medium: 
Nutrient Mixture F-12 (DMEM/F12) with 1% B27, 1% N2, 0.1 mM β - mercaptoetanol (Sigma), 2 mM glutamine 
GENE DESCRIPTION CATALOG NO.
ACTB Actin, beta Hs01060665_g1
CCNG1 Cyclin G1 Hs00171112_m1
COL6A3 collagen, type VI, alpha 3 Hs00915125_m1
H2AFX H2A histone family, member X Hs00266783_s1
H2AFZ H2A histone family, member Z Hs01888362_g1
HAT1 histone acetyltransferase 1 Hs00186320_m1
HDAC1 histone deacetylase 1 Hs02621185_s1
HIST1H1D histone cluster 1, H1d Hs00271187_s1
HIST1H2AB histone cluster 1, H2ab Hs01001083_s1
HIST1H2AC histone cluster 1, H2ac Hs00374312_s1
HIST1H2AH histone cluster 1, H2ah Hs00544732_s1
HIST1H2AJ histone cluster 1, H2aj Hs04191486_s1
HIST1H2AM histone cluster 1, H2am Hs01920904_s1
HIST1H2BB histone cluster 1, H2bb Hs00606684_s1
HIST1H2BG histone cluster 1, H2bg Hs00374317_s1
HIST1H2BH histone cluster 1, H2bh Hs00374322_s1
HIST1H3B histone cluster 1, H3b Hs00605810_s1
HIST1H3D histone cluster 1, H3d Hs00371415_s1
HIST1H4C histone cluster 1, H4c Hs00543883_s1
HIST1H4E histone cluster 1, H4e Hs00374346_s1
HIST1H4L histone cluster 1, H4l Hs00361930_s1
HIST2H2AB histone cluster 2, H2ab Hs00602439_s1
HIST2H2AC histone cluster 2, H2ac Hs00543838_s1
NANOG Nanog homeobox Hs02387400_g1
OCT4 POU class 5 homeobox 1 Hs00999632_g1
REX1 ZFP42 zinc finger protein Hs00399279_m1
SOX2 Sex determining region Y-box 2 Hs01053049_s1
TET1 tet methylcytosine dioxygenase 1 Hs00286756_m1
TET2 tet methylcytosine dioxygenase 2 Hs00325999_m1
TET3 tet methylcytosine dioxygenase 3 Hs00379125_m1
Table 1.  List of primers used for quantitative PCR analysis of human cells.
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(Sigma), 1 mM MEM Non-Essential Amino Acids, 0.05% bovine serum albumin (BSA, Sigma), and with 30 ng/mL 
activin A.
siRNA transfection. The targeting siRNA used in the present study was TET2 siRNA (Santa Cruz) and 
siRNA induced protein knock-down was carried out as previously described49. More in detail, cells were trans-
fected 24 hours before exposure to the modifier and during 5-aza-CR treatment, with 90 pM of siRNA, using 
Lipofectamine RNAi MAX Reagents diluted in Opti-MEM® Medium, following the manufacturer’s instruc-
tions. For negative controls, cells were incubated with Lipofectamine alone or with Lipofectamine plus 90 pM 
non-silencing siRNAs. The success of the silencing occurrence was assessed by monitoring the decrease of TET2 
protein. After transfection global DNA methylation was assessed as described below. All experiments were per-
formed three times in triplicate samples.
Global methylation analysis. Genomic DNA was extracted from untreated fibroblasts and after their 
siRNA transfection at different time points: T0, after 5-aza-CR treatment (Post 5-aza-CR), 24 and 48 hours after 
culture in fibroblast (FB), ESC or pancreatic induction (PANCR) media. PureLink® Genomic DNA Kits was used 
according to the manufacturer’s instructions. DNA was converted to single-stranded DNA by incubation at 95 °C 
for 5 min, followed by rapid chilling on ice. Samples were then digested to nucleosides by incubating the dena-
tured DNA with nuclease P1 for 2 h at 37 °C in 20 mM sodium acetate (pH 5.2). Alkaline phosphatase was added 
and incubated for 1 h at 37 °C in 100 mM Tris (pH 7.5). After centrifugation, the supernatant was used for ELISA 
assay using Global DNA Methylation ELISA Kit (5′ -methyl-2′ -deoxycytidine Quantitation; CELL BIOLABS) 
according to the manufacturer’s protocol.
DNA dot blot. Genomic DNA was extracted with PureLink® Genomic DNA Kits as previously described. 
DNA concentration was assessed with NanoDrop 8000 (Thermoscientific). Aliquots of 200 ng total DNA were 
prepared in a total volume of 2 μ L per sample and spotted onto nylon membranes (Hybond-N+ , Amersham). 
The DNA spots were air dried for 15 min, UV-crosslinked for 1 min and probed with primary antibodies against 
5-Carboxylcytosine (Active Motif, 1:1500) and 5-Formylcytosine (Active Motif, 1:1500). Dots were visualized 
with a WesternBreeze chemiluminescent kit. Signal intensity was quantified by densitometric analysis, using the 
Image J analysis software (National Institutes of Health).
Gene expression analysis. RNA was extracted with the TaqManGene Expression Cells to Ct kit (Applied 
Biosystems), and DNase I was added in lysis solution at 1:100 concentration, as indicated by the manufacturer’s 
instructions. Predesigned gene-specific primer and probe sets from TaqManGene Expression Assays (Applied 
Biosystems) were used for gene study (Table 1). PCR runs and fluorescence detection were carried out in a 7500 
Real-Time PCR System (Applied Biosystems). β -actin was used as internal standard. For each individual gene, the 
PROTEIN DESCRIPTION COMPANY CATALOG NO.
H2AX H2A histone family, member X(H2AFX), ELISA Kit MyBioSource MBS9335115
H2A.Z H2A histone family, member Z(H2AFZ), ELISA Kit MyBioSource MBS2025145
H1.3 Histone cluster 1, H1d (HIST1H1D), ELISA Kit MyBioSource MBS914357
H2A type 1-B/E Histone Cluster 1, H2ab (HIST1H2AB), ELISA Kit MyBioSource MBS9321468
H2A type 1-C Histone cluster 1, H2ac (HIST1H2AC), ELISA Kit MyBioSource MBS9333153
H2A type 1-H Histone cluster 1, H2ah (HIST1H2AH), ELISA Kit MyBioSource MBS9320153
H2A type 1-J Histone cluster 1, H2aj (HIST1H2AJ), ELISA Kit MyBioSource MBS9343145
H2A type 1 Not commercially available
H2B type 1-B Histone cluster 1, H2bb (HIST1H2BB), ELISA Kit MyBioSource MBS9317197
H2B type 1-C/E/F/G/I Histone cluster 1, H2bc (HIST1H2BG), ELISA Kit MyBioSource MBS9324014
H2B type 1-H Histone cluster 1, H2bh (HIST1H2BH), ELISA Kit MyBioSource MBS9319723
H3.1 Histone cluster H3.1 (HIST1H3A), ELISA Kit MyBioSource MBS937951
H4 Histone H4 (HIST1H4A), ELISA Kit MyBioSource MBS2884038
H2A type 2-B Histone cluster 2, H2ab (HIST2H2AB), ELISA Kit MyBioSource MBS9338734
H2A type 2-C histone cluster 2, H2ac (HIST2H2AC), ELISA Kit MyBioSource  MBS900872
Table 2.  List of ELISA kits used for quantification of histone protein levels.
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number of amplification cycles for the fluorescent reporter signal to reach a common threshold value (Ct) were 
estimated and then normalized against the Ct value obtained for β -actin of the same sample to give the Δ Ct value.
Quantification of histone protein levels. Cells were detached from the culture dish with trypsin and 
collected by centrifugation. They were then washed three times with cold PBS (1x) and subjected to ultrason-
ication. After centrifugation and dilution, samples were used for ELISA assay using the commercially available 
Enzyme-linked Immunoassorbent Assay Kit (MyBioSource) for the specific histone (Table 2), according to the 
manufacturer’s protocol. Optical density (O.D.) measurements were done using a Multiskan™ FC Microplate 
Photometer (Thermo Fisher) at the wavelength of 450 nm. Protein concentration in the samples was determined 
by comparing the O.D. of the samples to the standard curve.
Morphological analysis. Cells were analyzed at different time points: immediately before exposure to 
5-aza-CR (T0), after 5-aza-CR treatment (Post 5-aza-CR), 24 and 48 hours after culture in standard fibroblast 
(FB), in ESC or in pancreatic induction (PANCR) media.
Electron microscopy. Samples were fixed for 2 hours in 0.1 M cacodylate buffer pH 7.2, containing 2% glu-
taraldehyde. Specimens were then washed in the same buffer and post-fixed for 2 hours with 1% osmic acid in 
cacodylate buffer. After standard serial ethanol dehydration, specimens were embedded in an Epon-Araldite 
812 mixture. Sections were obtained with a Reichert Ultracut S ultratome (Leica, Austria). Semi-thin sections 
were stained by conventional methods (crystal violet and basic fuchsin) and observed under a light microscope 
(Olympus, Japan) to score cells for different morphological changes. Thin sections were stained by uranyl acetate 
and lead citrate and observed with a Jeol 1010 EX electron microscope (Jeol, Japan).
Statistical analysis. Statistical analysis was performed using Student t-test (SPSS 19.1; IBM). Data were pre-
sented as mean ± standard deviation (SD). Differences of p ≤ 0.05 were considered significant and were indicated 
with different superscripts.
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